Inventor · disambiguated record
Sameh Soliman
Also filed as: SOLIMAN SAMEH · SOLIMAN SAMEH S M
4 granted patents·5 pending applications·0 citations·filing 2017–2023
53Inventor score
Files withMILTENYI BIOTEC BV & CO KG4UNIV OF SHARJAH3LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT2
Top patents by PatentIndex Score
9 records- 0162US2025154546A1Use of 3'-oxymethylene alkyl disulfide protected nucleotides for enzymatic dna and rna synthesisMILTENYI BIOTEC BV & CO KG·Filed 2023·Application pending·0 cites
- 0261US2024094198A1Biological conjugates having an photogenerated acidic or basic releasable detection moiety on top of biological tissuesMILTENYI BIOTEC BV & CO KG·Filed 2023·Application pending·0 cites
- 0359US11767339B2Synthesis of reversible nucleotide terminators by in-situ thio-alkyl group transfer for use in DNA sequencing by synthesisMILTENYI BIOTEC BV & CO KG·Filed 2022·Granted Sep 26, 2023·0 cites·6 claims
- 0457US2023101711A1Labeled probes with differentially cleavable linkers and their use in de-coding dna and rna moleculesMILTENYI BIOTEC BV & CO KG·Filed 2022·Application pending·0 cites
- 0554US10877037B2Fungal toxins and methods related to the sameLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2017·Granted Dec 29, 2020·0 cites·13 claims
- 0652US2021179695A1Novel fungal toxins and methods related to the sameLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2020·Application pending·0 cites
- 0751US2024226128A1Novel compounds with dual inhibition activity against sars-cov-2 critical enzymes rdrp, mpro and human tmprss2UNIV OF SHARJAH·Filed 2022·Application pending·0 cites
- 0849US11608331B2Anti-SARS CoV-2 inhibitors by dual viral-host targetingUNIV OF SHARJAH·Filed 2021·Granted Mar 21, 2023·0 cites·5 claims
- 0938US11292776B2Small molecule inhibitors of fungal hyphae and biofilm formationUNIV OF SHARJAH·Filed 2019·Granted Apr 5, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Sameh Soliman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →